Publications by authors named "Francisca Lopes"

Claim this Profile
H
Hybrid Molecules of p53 Activators and Protoflavones to Target Multiple Myeloma.
Francisca Lopes, Gábor Girst, Rafael Rincón, Ricardo J F Ferreira, Lídia M Gonçalves

ChemMedChem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrroloquinolone-Based Compounds as a Novel Antimycobacterial Chemotype.
Marta Clariano, Diogo Nunes, Daniela Canudo, Daniela Maçãs, Bruno J L Castro, Francisca Lopes

ACS Med Chem Lett· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychiatric symptoms and specific cognitive domains in mild cognitive impairment.
Lucas Luchesi Barnes, Lucas Francisco Botequio Mella, Francisca Daniele Ferreira Lopes, Amilton Dos Santos, Paulo Dalgalarrondo

Dement Neuropsychol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New azaaurone derivatives as potential multitarget agents in HIV-TB coinfection.
Debora I Leite, Andre Campaniço, Pedro A G Costa, Isadora A Correa, Luciana J da Costa, Francisca Lopes

Arch Pharm (Weinheim)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic Stability.
André Campaniço, Shrika G Harjivan, Elisabete Freitas, Marco Serafini, M Manuela Gaspar, Francisca Lopes

ChemMedChem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Income inequalities beyond access to mental health care: a Dutch nationwide record-linkage cohort study of baseline disease severity, treatment intensity, and mental health outcomes.
Francisca Vargas Lopes, Bastian Ravesteijn, Tom Van Ourti, Carlos Riumallo-Herl

Lancet Psychiatry· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target Identification in Anti-Tuberculosis Drug Discovery.
Rita Capela, Rita Félix, Marta Clariano, Diogo Nunes, Maria de Jesus Perry, Francisca Lopes

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trade-offs during the COVID-19 pandemic: A discrete choice experiment about policy preferences in Portugal.
Luís Filipe, Sara Valente de Almeida, Eduardo Costa, Joana Gomes da Costa, Francisca Vargas Lopes

PLoS One· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of supported housing for individuals with mental disorders.
Francisca Vargas Lopes, Pieter Bakx, Sam Harper, Bastian Ravesteijn, Tom Van Ourti

Health Econ· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural experiments: A Nobel Prize awarded research design for strengthening causal inference on global health challenges.
Famke Jm Mölenberg, Francisca Vargas Lopes

J Glob Health· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient cost-sharing, mental health care and inequalities: A population-based natural experiment at the transition to adulthood.
Francisca Vargas Lopes, Carlos J Riumallo Herl, Johan P Mackenbach, Tom Van Ourti

Soc Sci Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological Evaluation and Mechanistic Studies of Quinolin-(1)-Imines as a New Chemotype against Leishmaniasis.
Ana Georgina Gomes-Alves, Margarida Duarte, Tânia Cruz, Helena Castro, Francisca Lopes

Antimicrob Agents Chemother· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing Latent Tuberculosis: New Advances in Mimicking the Disease, Discovering Key Targets, and Designing Hit Compounds.
André Campaniço, Shrika G Harjivan, Digby F Warner, Rui Moreira, Francisca Lopes

Int J Mol Sci· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concerns and adjustments: How the Portuguese population met COVID-19.
Sara Valente de Almeida, Eduardo Costa, Francisca Vargas Lopes, João Vasco Santos, Pedro Pita Barros

PLoS One· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel and Modified Neutrophil Elastase Inhibitor Loaded in Topical Formulations for Psoriasis Management.
Andreia Nunes, Joana Marto, Lídia Maria Gonçalves, Sandra Simões, Rita Félix, Francisca Lopes

Pharmaceutics· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Overview of Drug Resistance in Protozoal Diseases.
Rita Capela, Rui Moreira, Francisca Lopes

Int J Mol Sci· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azaaurones as Potent Antimycobacterial Agents Active against MDR- and XDR-TB.
André Campaniço, Marta P Carrasco, Mathew Njoroge, Ronnett Seldon, Kelly Chibale, Francisca Lopes

ChemMedChem· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoperoxide-8-aminoquinoline hybrids as dual-stage antimalarial agents with enhanced metabolic stability.
Rita Capela, Joana Magalhães, Daniela Miranda, Marta Machado, Margarida Sanches-Vaz, Francisca Lopes

Eur J Med Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug discovery in tuberculosis. New drug targets and antimycobacterial agents.
André Campaniço, Rui Moreira, Francisca Lopes

Eur J Med Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal.
Luis Silva Miguel, Francisca Vargas Lopes, Bernardete Pinheiro, Jingshu Wang, Ruifeng Xu

Value Health· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From hybrid compounds to targeted drug delivery in antimalarial therapy.
Rudi Oliveira, Daniela Miranda, Joana Magalhães, Rita Capela, Maria J Perry, Francisca Lopes

Bioorg Med Chem· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiplasmodial drugs in the gas phase: a CID and DFT study of quinolon-4(1H)-imine derivatives.
Paulo J Amorim Madeira, Ana Raquel Fernandes Sitoe, Daniel Gonçalves, Tiago Rodrigues, Rita C Guedes, Francisca Lopes

J Am Soc Mass Spectrom· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetraoxane-pyrimidine nitrile hybrids as dual stage antimalarials.
Rudi Oliveira, Rita C Guedes, Patrícia Meireles, Inês S Albuquerque, Lídia M Gonçalves, Francisca Lopes

J Med Chem· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel endoperoxide-based transmission-blocking antimalarials with liver- and blood-schizontocidal activities.
Daniela Miranda, Rita Capela, Inês S Albuquerque, Patrícia Meireles, Isa Paiva, Francisca Lopes

ACS Med Chem Lett· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flavones as isosteres of 4(1H)-quinolones: discovery of ligand efficient and dual stage antimalarial lead compounds.
Tiago Rodrigues, Ana S Ressurreição, Filipa P da Cruz, Inês S Albuquerque, Jiri Gut, Francisca Lopes

Eur J Med Chem· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis